Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Crohn Disease: HELP
Articles by Katharina A. Schindlbeck
Based on 1 article published since 2010
(Why 1 article?)
||||

Between 2010 and 2020, Katharina A. Schindlbeck wrote the following article about Crohn Disease.
 
+ Citations + Abstracts
1 Article Restless legs syndrome is a relevant comorbidity in patients with inflammatory bowel disease. 2018

Becker, Janek / Berger, Felix / Schindlbeck, Katharina A / Poddubnyy, Denis / Koch, Peter M / Preiß, Jan C / Siegmund, Britta / Marzinzik, Frank / Maul, Jochen. ·Department of Medicine (Gastroenterology, Infectious Diseases, Rheumatology), Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, Berlin, Germany. · Department of Neurology, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, Berlin, Germany. · Center for Neurosciences, Feinstein Institute for Medical Research, Manhasset, NY, USA. · Gastroenterologie, Hepatologie und Diabetologie, Vivantes Klinikum Neukölln, Berlin, Germany. · Department of Medicine (Gastroenterology, Infectious Diseases, Rheumatology), Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, Berlin, Germany. jochen.maul@charite.de. · Gastroenterologie am Bayerischen Platz, Innsbrucker Str. 58, 10825, Berlin, Germany. jochen.maul@charite.de. ·Int J Colorectal Dis · Pubmed #29610943.

ABSTRACT: BACKGROUND AND AIMS: In patients with inflammatory bowel disease (IBD), restless legs syndrome (RLS) may occur as an extraintestinal disease manifestation. Iron deficiency (ID) or folate deficiency/vitamin B METHODS: Patients were screened for ID and RLS by a gastroenterologist. If RLS was suspected, a neurologist was consulted for definitive diagnosis and severity. Patients with RLS and ID, FD, or VB RESULTS: A total of 353 IBD patients were included. Prevalence for RLS was 9.4% in Crohn's disease (CD) and 8% in ulcerative colitis (UC). Prevalence for the subgroup of clinically relevant RLS (symptoms ≥ twice/week with at least moderate distress) was 7.1% (n = 16) for CD and 4.8% (n = 6) for UC. 38.7% of RLS patients presented with ID, FD, and/or VB CONCLUSION: Although the overall prevalence of RLS in IBD did not differ to the general population, clinically relevant RLS was more frequent in IBD patients and, therefore, it is important for clinicians to be aware of RLS symptoms. Though for definite diagnosis and proper treatment of RLS, a neurologist must be consulted. Additionally, iron supplementation of IBD patients with ID can improve RLS symptoms. TRIAL REGISTRATION: ClinicalTrials.gov No. NCT03457571.